Trevi Therapeutics (TRVI) Interest & Investment Income (2018 - 2022)
Trevi Therapeutics (TRVI) posted quarterly Interest & Investment Income of $1.9 million for Q4 2025, up 125.74% year-over-year from $843000.0 in Q4 2024, and down 9.42% quarter-over-quarter from $2.1 million in Q3 2025.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Interest & Investment Income (2018 - 2022) Analysis & Trends
Trevi Therapeutics' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $1.9 million for Q4 2025.
- In Q4 2025, Interest & Investment Income rose 125.74% year-over-year to $1.9 million; the TTM figure through Dec 2025 stood at $6.3 million (up 73.63% YoY), while the FY2025 annual figure was $6.5 million, up 81.45% from the prior year.
- Interest & Investment Income for Q4 2025 stood at $1.9 million, down from $2.1 million in the prior quarter.
- The five-year high for Interest & Investment Income was $2.1 million in Q3 2025, with the low at $826000.0 in Q3 2024.
- The 3-year median for Interest & Investment Income is $1.1 million (2023), against an average of $1.3 million.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income tumbled 30.18% in 2024, then jumped 154.36% in 2025.
- Trevi Therapeutics' Interest & Investment Income stood at $1.1 million in 2023, then declined by 25.86% to $843000.0 in 2024, then jumped by 125.74% to $1.9 million in 2025.
- Business Quant data shows TRVI's Interest & Investment Income at $1.9 million in Q4 2025, $2.1 million in Q3 2025, and $1.4 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Trevi Therapeutics | 2.71 Bn | 2.71 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 1.12 Mn |
| Sep 30, 2022 | 424,000.00 |
| Jun 30, 2022 | 195,000.00 |
| Mar 31, 2022 | 4,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | 4,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 14,000.00 |
| Mar 31, 2020 | 157,000.00 |
| Dec 31, 2019 | 225,000.00 |
| Sep 30, 2019 | 280,000.00 |
| Jun 30, 2019 | 229,000.00 |
| Mar 31, 2019 | 58,000.00 |
| Dec 31, 2018 | 46,000.00 |
| Sep 30, 2018 | 27,000.00 |
| Jun 30, 2018 | 38,000.00 |
| Mar 31, 2018 | 45,000.00 |